Association between age at first reported e-cigarette use and subsequent regular e-cigarette, ever cigarette and regular cigarette use.

Adolescents E-cigarettes electronic nicotine delivery systems harm reduction intervention smoking

Journal

Addiction (Abingdon, England)
ISSN: 1360-0443
Titre abrégé: Addiction
Pays: England
ID NLM: 9304118

Informations de publication

Date de publication:
07 2021
Historique:
revised: 01 10 2020
received: 05 06 2020
accepted: 16 12 2020
pubmed: 5 1 2021
medline: 30 9 2021
entrez: 4 1 2021
Statut: ppublish

Résumé

Association of electronic cigarette use and subsequent smoking has received considerable attention, although age of first use has not. This study tested differences in regular (e-cigarettes, cigarettes) and ever (cigarettes) use between e-cigarette user groups: early versus never users, late versus never users, early versus late users and effects of controlling for covariates. Prospective study with 12- and 24-month follow-up of e-cigarette/cigarette ever/regular use with data from an intervention. Forty-five schools in England (Staffordshire and Yorkshire). Never smokers (3289 13-14-year-olds) who were part of a cluster randomized controlled trial. The sample was divided into groups of e-cigarette users: early users (at 13-14 years), late users (at 14-15 years) and never users (at 13-14 and 14-15 years). Dependent variables were self-reported regular e-cigarette and cigarette use and ever cigarette use at 15-16 years. Covariates were assessed. Early and late users compared with never users were significantly more likely to be regular e-cigarette users [early: odds ratio (OR) = 9.42, 95% confidence interval (CI) = 5.38, 16.49, P < 0.001; late: OR = 6.89, 95% CI = 4.11, 11.54, P < 0.001], ever cigarette users (early: OR = 7.96, 95% CI = 6.02, 10.53, P < 0.001; late: OR = 5.13, 95% CI = 3.85, 6.84, P < 0.001) and regular cigarette users (early: OR = 7.80, 95% CI = 3.99, 15.27, P < 0.001; late: OR = 4.34, 95% CI = 1.93, 9.77, P < 0.001) at age 15-16 years. Late users compared with early users had significantly lower rates of ever use of cigarettes at 15-16 years (OR = 0.48, 95% CI = 0.35, 0.66, P < 0.001), although this difference was non-significant at 12 months after first use of e-cigarettes (OR = 0.89, 95% CI = 0.64, 1.25, P = 0.498). Controlling for covariates did not change the findings. Adolescents in England who report using e-cigarettes at age 13-14 years have higher rates of subsequently initiating cigarette use than adolescents who report using e-cigarettes at age 14-15 years, a difference that may be attributable to a longer period of time to initiate cigarette use in former group.

Sections du résumé

BACKGROUND AND AIMS
Association of electronic cigarette use and subsequent smoking has received considerable attention, although age of first use has not. This study tested differences in regular (e-cigarettes, cigarettes) and ever (cigarettes) use between e-cigarette user groups: early versus never users, late versus never users, early versus late users and effects of controlling for covariates.
DESIGN
Prospective study with 12- and 24-month follow-up of e-cigarette/cigarette ever/regular use with data from an intervention.
SETTING
Forty-five schools in England (Staffordshire and Yorkshire).
PARTICIPANTS
Never smokers (3289 13-14-year-olds) who were part of a cluster randomized controlled trial.
MEASUREMENTS
The sample was divided into groups of e-cigarette users: early users (at 13-14 years), late users (at 14-15 years) and never users (at 13-14 and 14-15 years). Dependent variables were self-reported regular e-cigarette and cigarette use and ever cigarette use at 15-16 years. Covariates were assessed.
FINDINGS
Early and late users compared with never users were significantly more likely to be regular e-cigarette users [early: odds ratio (OR) = 9.42, 95% confidence interval (CI) = 5.38, 16.49, P < 0.001; late: OR = 6.89, 95% CI = 4.11, 11.54, P < 0.001], ever cigarette users (early: OR = 7.96, 95% CI = 6.02, 10.53, P < 0.001; late: OR = 5.13, 95% CI = 3.85, 6.84, P < 0.001) and regular cigarette users (early: OR = 7.80, 95% CI = 3.99, 15.27, P < 0.001; late: OR = 4.34, 95% CI = 1.93, 9.77, P < 0.001) at age 15-16 years. Late users compared with early users had significantly lower rates of ever use of cigarettes at 15-16 years (OR = 0.48, 95% CI = 0.35, 0.66, P < 0.001), although this difference was non-significant at 12 months after first use of e-cigarettes (OR = 0.89, 95% CI = 0.64, 1.25, P = 0.498). Controlling for covariates did not change the findings.
CONCLUSIONS
Adolescents in England who report using e-cigarettes at age 13-14 years have higher rates of subsequently initiating cigarette use than adolescents who report using e-cigarettes at age 14-15 years, a difference that may be attributable to a longer period of time to initiate cigarette use in former group.

Identifiants

pubmed: 33394523
doi: 10.1111/add.15386
pmc: PMC8609424
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1839-1847

Subventions

Organisme : Medical Research Council
ID : MR/J000264/1
Pays : United Kingdom

Informations de copyright

© 2021 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.

Références

Tob Control. 2017 Aug 17;:
pubmed: 28818839
Am J Public Health. 2020 Feb;110(2):163-165
pubmed: 31855480
JAMA. 2015 Aug 18;314(7):700-7
pubmed: 26284721
BMC Public Health. 2013 Jan 19;13:54
pubmed: 23332020
Am J Public Health. 1987 Nov;77(11):1435-8
pubmed: 3661797
JAMA Pediatr. 2015 Nov;169(11):1018-23
pubmed: 26348249
JAMA Pediatr. 2018 Feb 1;172(2):181-187
pubmed: 29297010
J Dent Res. 1987 Oct;66(10):1597-601
pubmed: 3305621
Tob Control. 2020 Jul;29(4):425-431
pubmed: 31253718
Addiction. 2021 Jul;116(7):1839-1847
pubmed: 33394523
Tob Control. 2020 Mar 10;:
pubmed: 32156694
Tob Control. 2021 Mar;30(2):212-220
pubmed: 32184339
J Consult Clin Psychol. 2019 May;87(5):422-432
pubmed: 30843703
Nicotine Tob Res. 2018 Jul 9;20(8):923-930
pubmed: 29986103
Tob Control. 2017 Jul 22;:
pubmed: 28735273
Health Psychol. 2010 Sep;29(5):529-38
pubmed: 20836608
Pediatrics. 2018 Dec;142(6):
pubmed: 30397165

Auteurs

Mark Conner (M)

School of Psychology, University of Leeds, Leeds, UK.

Sarah Grogan (S)

Department of Psychology, Manchester Metropolitan University, Manchester, UK.

Ruth Simms-Ellis (R)

School of Psychology, University of Leeds, Leeds, UK.

Lisa Cowap (L)

Centre for Psychological Research, Science Centre, Staffordshire University, Stoke-on-Trent, UK.

Christopher J Armitage (CJ)

Manchester Centre for Health Psychology, Division of Psychology and Mental Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.

Robert West (R)

Institute of Health Sciences, University of Leeds, Leeds, UK.

Anna-Marie Marshall (AM)

Department of Health Sciences, University of York, York, UK.

Kamran Siddiqi (K)

Department of Health Sciences, University of York, York, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH